ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Therapeutic potential of paeoniflorin in atherosclerosis: A cellular action and mechanism-based perspective

Yu, Wei; Ilyas, Iqra; Hu, Xuerui; Xu, Suowen; Yu, Hui*1
Frontiers in Immunology2022-12-21DOI: 10.3389/fimmu.2022.1072007
4被引19阅读
引用收藏
分享

摘要

Epidemiological studies have shown that the incidence, prevalence and mortality of atherosclerotic cardiovascular disease (ASCVD) are increasing globally. Atherosclerosis is characterized as a chronic inflammatory disease which involves inflammation and immune dysfunction. P. lactiflora Pall. is a plant origin traditional medicine that has been widely used for the treatment of various diseases for more than a millennium in China, Japan and Korean. Paeoniflorin is a bioactive monomer extracted from P. lactiflora Pall. with anti-atherosclerosis effects. In this article, we comprehensively reviewed the potential therapeutic effects and molecular mechanism whereby paeoniflorin protects against atherosclerosis from the unique angle of inflammation and immune-related pathway dysfunction in vascular endothelial cells, smooth muscle cells, monocytes, macrophages, platelets and mast cells. Paeoniflorin, with multiple protective effects in atherosclerosis, has the potential to be used as a promising therapeutic agent for the treatment of atherosclerosis and its complications. We conclude with a detailed discussion of the challenges and future perspective of paeoniflorin in translational cardiovascular medicine.

学科与关键词

关键词
atherosclerosiscardiovascular diseasepaeoniflorininflammationimmunity
相关
加载中…
  • A review on therapeutical potential of paeonol in atherosclerosis
    Yu, Wei*; Ilyas, Iqra; Aktar, Nasrin; Xu, Suowen*Frontiers in Pharmacology, 2022, 13: 950337.被引 10
  • Emodin in atherosclerosis prevention: Pharmacological actions and therapeutic potential
    Luo, Ning; Fang, Jian; Wei, Liqin; Sahebkar, Amirhossein; Little, Peter J.; Xu, Suowen; Luo, ChongBin*; Li, GuangNing*European Journal of Pharmacology, 2021, 890: 173617.被引 21
  • Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis
    Bi, Yiming; Han, Xin; Lai, Yigui; Fu, Yingchang; Li, Kongzheng; Zhang, Wei; Wang, Qiang; Jiang, Xuefeng; Zhou, Yingchun*; Liang, Hongfeng*; Fan, Huijie*Journal of Ethnopharmacology, 2021, 278: 114278.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-12-21
卷期
第 13 卷
页码
1072007
DOI
10.3389/fimmu.2022.1072007
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Anhui Provincial Key Research and Development Program; [202104j07020051]

作者

  • Y

    Yu, Wei (第一作者)

  • I

    Ilyas, Iqra

    1 · univ sci & technol china · ustc

查看全部 5 位作者收起作者
  • H

    Hu, Xuerui

    anhui univ

  • X

    Xu, Suowen

    1 · univ sci & technol china · ustc

  • Y

    Yu, Hui (通讯)

    hebei univ technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417